Here you can access stories featured on our instagram page. Want more biosimilar news? Sign up for our weekly newsletter, delivered to your inbox every Wednesday here.
ye on Pharma: Biocon Reports Its Highest-Ever Revenue and Profit Growth for Q3
eview Points to Nocebo Effect as a Cause of Higher Discontinuation Rates for Biosimilars
ncreases in Insulin Prices Drove Spending Over 4 Years, Report Says
uropean Report Says M&As Affecting Biosimilars Need Scrutiny